» Articles » PMID: 24618833

Widespread Nanoparticle-assay Interference: Implications for Nanotoxicity Testing

Overview
Journal PLoS One
Date 2014 Mar 13
PMID 24618833
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

The evaluation of engineered nanomaterial safety has been hindered by conflicting reports demonstrating differential degrees of toxicity with the same nanoparticles. The unique properties of these materials increase the likelihood that they will interfere with analytical techniques, which may contribute to this phenomenon. We tested the potential for: 1) nanoparticle intrinsic fluorescence/absorbance, 2) interactions between nanoparticles and assay components, and 3) the effects of adding both nanoparticles and analytes to an assay, to interfere with the accurate assessment of toxicity. Silicon, cadmium selenide, titanium dioxide, and helical rosette nanotubes each affected at least one of the six assays tested, resulting in either substantial over- or under-estimations of toxicity. Simulation of realistic assay conditions revealed that interference could not be predicted solely by interactions between nanoparticles and assay components. Moreover, the nature and degree of interference cannot be predicted solely based on our current understanding of nanomaterial behaviour. A literature survey indicated that ca. 95% of papers from 2010 using biochemical techniques to assess nanotoxicity did not account for potential interference of nanoparticles, and this number had not substantially improved in 2012. We provide guidance on avoiding and/or controlling for such interference to improve the accuracy of nanotoxicity assessments.

Citing Articles

Tattoo Ink Metal Nanoparticles: Assessment of Toxicity In Vitro and with a Novel Human Ex Vivo Model.

Battistini B, Lulli D, Bocca B, Carbone M, Ramondino C, Caimi S Nanomaterials (Basel). 2025; 15(4).

PMID: 39997833 PMC: 11858130. DOI: 10.3390/nano15040270.


Save Your Tears for the Toxicity Assays-Carbon Nanotubes Still Fooling Scientists.

Suni J, Valkama S, Peltola E ACS Omega. 2025; 10(6):5554-5562.

PMID: 39989827 PMC: 11840583. DOI: 10.1021/acsomega.4c08211.


When conventional approach in toxicity assays falls short for nanomedicines: a case study with nanoemulsions.

Nikolic I, dokovic J, Mehn D, Guerrini G, Savic S, Jordan O Drug Deliv Transl Res. 2025; .

PMID: 39779651 DOI: 10.1007/s13346-024-01776-7.


Electronic structure, global reactivity descriptors and nonlinear optical properties of glycine interacted with ZnO, MgO and CaO for bacterial detection.

Sabry N, Badry R, Abdel-Gawad F, Elhaes H, Ibrahim M Sci Rep. 2024; 14(1):22801.

PMID: 39353963 PMC: 11445471. DOI: 10.1038/s41598-024-72846-6.


Differentially Induced Autophagy by Engineered Nanomaterial Treatment Has an Impact on Cellular Homeostasis and Cytotoxicity.

Alcolea-Rodriguez V, Dumit V, Ledwith R, Portela R, Banares M, Haase A Nano Lett. 2024; 24(38):11793-11799.

PMID: 39271139 PMC: 11440646. DOI: 10.1021/acs.nanolett.4c01573.


References
1.
Fenniri H, Deng B, Ribbe A, Hallenga K, Jacob J, Thiyagarajan P . Entropically driven self-assembly of multichannel rosette nanotubes. Proc Natl Acad Sci U S A. 2002; 99 Suppl 2:6487-92. PMC: 128555. DOI: 10.1073/pnas.032527099. View

2.
Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson K . Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008; 105(38):14265-70. PMC: 2567179. DOI: 10.1073/pnas.0805135105. View

3.
Zhong W . Nanomaterials in fluorescence-based biosensing. Anal Bioanal Chem. 2009; 394(1):47-59. DOI: 10.1007/s00216-009-2643-x. View

4.
Hikosaka K, Kim J, Kajita M, Kanayama A, Miyamoto Y . Platinum nanoparticles have an activity similar to mitochondrial NADH:ubiquinone oxidoreductase. Colloids Surf B Biointerfaces. 2008; 66(2):195-200. DOI: 10.1016/j.colsurfb.2008.06.008. View

5.
Monteiro-Riviere N, Inman A, Zhang L . Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol. 2008; 234(2):222-35. DOI: 10.1016/j.taap.2008.09.030. View